YOUR SEARCH FOR Text 261 RESULTS
31 of Total
Corporate Governance | Incyte
Corporate Governance Committee Charters Audit & Finance Committee (opens in new window) Compensation Committee (opens in new window) Nominating
32 of Total
Events & Presentations | Incyte
Events & Presentations Events Corporate Presentations Scientific Presentations The information contained in prior presentation materials and
33 of Total
Incyte Investor Event- ESMO 2025 | Incyte
Event Details Events Corporate Presentations Scientific Presentations Incyte Investor Event- ESMO 2025 Oct 19, 2025 at 7:30 PM CEST Click here for
34 of Total
Q2 2025 Incyte Corporation Earnings Conference Call | Incyte
Event Details Events Corporate Presentations Scientific Presentations Q2 2025 Incyte Corporation Earnings Conference Call Jul 29, 2025 at 8:00 AM EDT
35 of Total
Q3 2025 Incyte Corporation Earnings Conference Call | Incyte
Event Details Events Corporate Presentations Scientific Presentations Q3 2025 Incyte Corporation Earnings Conference Call Oct 28, 2025 at 8:00 AM EDT
36 of Total
Financials | Incyte
Financials Annual Reports Quarterly Reports SEC Filings The information contained in prior reports should be considered accurate only as of the date
37 of Total
Financials | Incyte
Financials Annual Reports Quarterly Reports SEC Filings The information contained in prior press releases, reports, presentations and other materials
38 of Total
Financials | Incyte
Financials Annual Reports Quarterly Reports SEC Filings Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings
39 of Total
Data from Incyte’s TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the Eu
Press Release View all news Data from Incyte’s TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the European Society of
40 of Total
Incyte Announces New Data from Phase 3b TRuE-AD4 Trial of Opzelura® (Ruxolitinib Cream) in Adults wi
Press Release View all news Incyte Announces New Data from Phase 3b TRuE-AD4 Trial of Opzelura® (Ruxolitinib Cream) in Adults with Moderate Atopic